These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29866054)

  • 1. MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4.
    Lei W; Yan C; Ya J; Yong D; Yujun B; Kai L
    BMC Cancer; 2018 Jun; 18(1):631. PubMed ID: 29866054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
    Gao Y; Feng Y; Shen JK; Lin M; Choy E; Cote GM; Harmon DC; Mankin HJ; Hornicek FJ; Duan Z
    Sci Rep; 2015 Jun; 5():11365. PubMed ID: 26079799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.
    Pu Y; Zhao F; Li Y; Cui M; Wang H; Meng X; Cai S
    BMC Cancer; 2017 Jan; 17(1):45. PubMed ID: 28073349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
    Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene.
    Zang C; Zhao F; Hua L; Pu Y
    Cancer Cell Int; 2018; 18():186. PubMed ID: 30479565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1.
    Wang M; Li W; Han G; Bai X; Xie J
    Protein Pept Lett; 2024; 31(7):559-568. PubMed ID: 39076089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
    Liu Q; Yang G; Qian Y
    Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression.
    Wu Y; Xie Z; Chen J; Chen J; Ni W; Ma Y; Huang K; Wang G; Wang J; Ma J; Shen S; Fan S
    Mol Cancer; 2019 Apr; 18(1):73. PubMed ID: 30940151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene.
    Pu Y; Zhao F; Wang H; Cai W; Gao J; Li Y; Cai S
    Oncotarget; 2016 May; 7(19):28420-34. PubMed ID: 27056900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
    Duan Z; Choy E; Harmon D; Liu X; Susa M; Mankin H; Hornicek F
    Mol Cancer Ther; 2011 Aug; 10(8):1337-45. PubMed ID: 21666078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
    Zeng B; Shi W; Tan G
    BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene.
    Pu Y; Zhao F; Wang H; Cai S
    Sci Rep; 2017 Mar; 7():44218. PubMed ID: 28281638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
    Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
    Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li S; Wu X; Pei Y; Wang W; Zheng K; Qiu E; Zhang X
    DNA Cell Biol; 2019 Nov; 38(11):1323-1337. PubMed ID: 31536386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma.
    Ye P; Ke X; Zang X; Sun H; Dong Z; Lin J; Wang L; Liu W; Miao G; Tan Y; Tong W; Xiao H; Gao L
    Biomed Pharmacother; 2018 May; 101():219-227. PubMed ID: 29494959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8.
    Cui Y; Wu F; Tian D; Wang T; Lu T; Huang X; Zhang P; Qin L
    Oncol Rep; 2018 Apr; 39(4):1649-1657. PubMed ID: 29436681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-199a-3p suppresses neuroinflammation by directly targeting MyD88 in a mouse model of bone cancer pain.
    Saadh MJ; Rashed AB; Jamal A; Castillo-Acobo RY; Kamal MA; Cotrina-Aliaga JC; Gonzáles JLA; Alothaim AS; Alhoqail WA; Ahmad F; Lakshmaiya N; Amin AH; Younus DG; Rojas GGR; Bahrami A; Akhavan-Sigari R
    Life Sci; 2023 Nov; 333():122139. PubMed ID: 37783266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis.
    Wu Z; Gong Q; Yu Y; Zhu J; Li W
    BMC Pulm Med; 2020 Jan; 20(1):10. PubMed ID: 31931771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
    Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
    Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.